Personal information

Verified email domains

Activities

Works (7)

Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an Autophagy-Independent Pathway

Cancers
2025-02 | Journal article | Author
Contributors: Yi Ma; Chelsea Dumesny; Li Dong; Ching-Seng Ang; Mehrdad Nikfarjam; Hong Q He
Source: check_circle
Multidisciplinary Digital Publishing Institute

A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine

International Journal of Molecular Sciences
2024-10 | Journal article | Author
Contributors: Hong Q He; Chelsea Dumesny; Judith Carrall; Carolyn T. Dillon; Katja I. de Roo; Mal Eutick; Li Dong; Graham S. Baldwin; Mehrdad Nikfarjam
Source: check_circle
Multidisciplinary Digital Publishing Institute

PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response

Cells
2023-11 | Journal article | Author
Contributors: Arian Ansardamavandi; Mehrdad Nikfarjam; Hong Q He
Source: check_circle
Multidisciplinary Digital Publishing Institute

P-21 Activated Kinases in Liver Disorders

Cancers
2023-01 | Journal article | Author
Contributors: Xun Qiu; Hanzhi Xu; Kai Wang; Fengqiang Gao; Xiao Xu; Hong Q He
Source: check_circle
Multidisciplinary Digital Publishing Institute

Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway

International Journal of Molecular Sciences
2020-10 | Journal article | Author
Contributors: Yang Yang; Nhi Huynh; Chelsea Dumesny; Kai Wang; Hong Q He; Mehrdad Nikfarjam
Source: check_circle
Multidisciplinary Digital Publishing Institute

A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine

Source: check_circle
Multidisciplinary Digital Publishing Institute

The PAK Inhibitor PF-3758309 Promotes the Inhibitory Effects of Multiple Chemotherapeutic Reagents on Patient-Derived Pancreatic Cancer Cell Lines

Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (16 reviews for 11 publications/grants)

Review activity for Biomedicine & pharmacotherapy. (1)
Review activity for Cancer drug resistance. (2)
Review activity for Cancer letters. (3)
Review activity for Cancers. (2)
Review activity for Gastroenterology. (1)
Review activity for Heliyon. (1)
Review activity for International journal of biological macromolecules. (1)
Review activity for Molecular biology reports. (1)
Review activity for Oncogene. (1)
Review activity for Pharmacological research. (2)
Review activity for Translational oncology. (1)